Virax Biolabs Group (VRAX) Institutional Ownership $1.75 -0.14 (-7.41%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Virax Biolabs Group (NASDAQ:VRAX)CurrentInstitutional OwnershipPercentage8.61%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$178.12KNumber ofInstitutional Sellers(last 12 months)0 Get VRAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virax Biolabs Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Virax Biolabs Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Armistice Capital LLC121,999$178K0.0%N/A7.871% (Data available from 1/1/2016 forward) VRAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VRAX shares? During the previous two years, the following institutional investors and hedge funds held shares of Virax Biolabs Group shares: Armistice Capital LLC ($178K).Learn more on VRAX's institutional investors. What percentage of Virax Biolabs Group stock is owned by institutional investors? 8.61% of Virax Biolabs Group stock is owned by institutional investors. Learn more on VRAX's institutional investor holdings. Which institutional investors have been buying Virax Biolabs Group stock? The following institutional investors have purchased Virax Biolabs Group stock in the last 24 months: Armistice Capital LLC ($122.00K). How much institutional buying is happening at Virax Biolabs Group? Institutional investors have bought a total of 121,999 shares in the last 24 months. This purchase volume represents approximately $178.12K in transactions. Related Companies Tenax Therapeutics Institutional Ownership Citius Pharmaceuticals Institutional Ownership Finch Therapeutics Group Institutional Ownership Cognition Therapeutics Institutional Ownership Cadrenal Therapeutics Institutional Ownership MIRA Pharmaceuticals Institutional Ownership Unity Biotechnology Institutional Ownership Carisma Therapeutics Institutional Ownership Pieris Pharmaceuticals Institutional Ownership Aprea Therapeutics Institutional Ownership This page (NASDAQ:VRAX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
